Susquehanna International Group, LLP Synlogic, Inc. Transaction History

Susquehanna International Group, LLP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.89 - $2.47 $82,119 - $227,904	-92,269 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$1.63 - $2.55 $66,254 - $103,649	-40,647 Reduced 30.58%	92,269 $221,000
Q4 2021 Feb 14, 2022	BUY	$2.27 - $3.0 $189,156 - $249,987	83,329 Added 168.05%	132,916 $322,000
Q3 2021 Nov 15, 2021	BUY	$2.45 - $4.1 $74,590 - $124,824	30,445 Added 159.05%	49,587 $151,000
Q2 2021 Aug 11, 2021	SELL	$3.0 - $4.39 $13,257 - $19,399	-4,419 Reduced 18.76%	19,142 $74,000
Q1 2021 May 17, 2021	BUY	$2.2 - $5.05 $19,278 - $44,253	8,763 Added 59.22%	23,561 $84,000
Q4 2020 Feb 16, 2021	SELL	$1.85 - $2.54 $53,485 - $73,433	-28,911 Reduced 66.14%	14,798 $32,000
Q2 2020 Aug 14, 2020	BUY	$1.59 - $2.51 $69,497 - $109,709	43,709 New	43,709 $89,000
Q4 2019 Feb 14, 2020	SELL	$1.96 - $2.81 $36,160 - $51,841	-18,449 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.12 - $9.37 $39,111 - $172,867	18,449 New	18,449 $42,000
Q2 2018 Aug 14, 2018	SELL	$9.01 - $13.33 $525,255 - $777,099	-58,297 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$9.38 - $12.12 $546,825 - $706,559	58,297 New	58,297 $547,000

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $99M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.